Cargando…
Targeting neurotensin as a potential novel approach for the treatment of autism
The pathophysiology of autism remains obscure. Recently, serum neurotensin levels in children with autistic disorder have been found to be higher than those of normal children. Neurotensin is known to intensify neuronal NMDA-mediated glutamate signaling, which may cause apoptosis in autism. Further,...
Autor principal: | Ghanizadeh, Ahmad |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2958902/ https://www.ncbi.nlm.nih.gov/pubmed/20920308 http://dx.doi.org/10.1186/1742-2094-7-58 |
Ejemplares similares
-
Neurotensin protects pancreatic beta cells from serum deprivation
por: Dicou, Eleni
Publicado: (2008) -
A commentary on “A young man with acute dilated cardiomyopathy associated with methylphenidate”
por: Ghanizadeh, Ahmad
Publicado: (2009) -
Interferon beta (IFN-β) treatment exerts potential neuroprotective effects through neurotrophic factors and novel neurotensin/neurotensin high affinity receptor 1 pathway
por: Wang, Qin, et al.
Publicado: (2015) -
Design, Synthesis,
and Biological Evaluation of the
First Radio-Metalated Neurotensin Analogue Targeting Neurotensin Receptor
2
por: Bodin, Sacha, et al.
Publicado: (2023) -
N-acetylcysteine for treatment of autism, a case report
por: Ghanizadeh, Ahmad, et al.
Publicado: (2012)